Related references
Note: Only part of the references are listed.Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with checkpoint inhibitors
Ali Raza Khaki et al.
CANCER (2020)
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial
Andrea B. Apolo et al.
LANCET ONCOLOGY (2020)
Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
Jonathan E. Rosenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
Y. Loriot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
Lorenza Landi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population
Andrea Necchi et al.
CLINICAL GENITOURINARY CANCER (2018)
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
Sabine Schmid et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Bone Metastases Pattern in Newly Diagnosed Metastatic Bladder Cancer: A Population-Based Study
Chao Zhang et al.
JOURNAL OF CANCER (2018)
Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
Andrea Necchi et al.
EUROPEAN UROLOGY (2017)
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
Roland Seiler et al.
EUROPEAN UROLOGY (2017)
Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world
Satoru Taguchi et al.
WORLD JOURNAL OF UROLOGY (2016)
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naive Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer
David J. McConkey et al.
EUROPEAN UROLOGY (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study
Satoru Taguchi et al.
INTERNATIONAL JOURNAL OF UROLOGY (2015)
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi et al.
CANCER CELL (2014)
Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy
Matthew D. Galsky et al.
CANCER (2013)
Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy
Andrea B. Apolo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study
Yoo-Joung Ko et al.
LANCET ONCOLOGY (2013)
Metastatic Pattern of Bladder Cancer: Correlation With the Characteristics of the Primary Tumor
Atul B. Shinagare et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Clinical features of metastatic bone disease and risk of skeletal morbidity
Robert E. Coleman
CLINICAL CANCER RESEARCH (2006)
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium
Christopher J. Sweeney et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Share Paper
